Antifungal drugs prescription pattern in a tertiary care teaching hospital in South India

Background: Fungal infections are a major threat to human health. Immunocompromised patients are more susceptible to fungal infections which may be from superficial to systemic fungal infections. Proper diagnosis and appropriate prescription is essential for management of these fungal infections. Inappropriate use of antifungal agents can lead to antifungal resistance and adverse effects caused by them. Therefore, this study was carried out to understand the prescription pattern of antifungal drugs among patients from various departments such as general medicine, dermatology, obstetrics, and gynaecology at a tertiary care hospital in South India. Aims and Objectives: The objectives of the study are as follows: (i) To understand the Antifungal prescription practices in our hospital and (ii) to improve the rational use of antifungal drugs. Materials and Methods: This was an observational and cross-sectional study. Inpatients and outpatients of age above 18 years attending Government Omandurar Medical College, Chennai, during the study period of 2 months who were prescribed antifungal drugs were included in this study. The prescriptions of 342 patients were collected and data including age, gender, diagnosis, name of the antifungal drugs, route of administration, dosage form, and duration of treatment were reviewed. Out of 342 prescriptions, 92 contained more than one antifungal drugs in their prescriptions. The data collected were analyzed for frequency of antifungal drugs prescription and percentage values calculated. Results: In our study, females (n = 198; 57.95%) were prescribed antifungal drugs more than males. Most of them are out patients from the age group of 31–50 years (n = 159; 46.49%). Dermatology (n = 272; 79.53%) department had the most number of antifungal prescriptions. Tinea corporis (n = 138; 40.35%) was the most common fungal infection to be prescribed. Clotrimazole (n = 115; 27.89%) was the most commonly prescribed antifungal drug followed by Fluconazole (n = 105; 24.19%). Topical route (n = 268; 61.75%) was the most common route of administration of antifungal drugs followed by oral and parental routes, respectively. Conclusion: This study report helped us to analyze the prescribing pattern of antifungal drugs in our tertiary care hospital. This gave an idea to create guidelines for the rational use of antifungal drugs in our institution.

Cost variation analysis of different brands of antifungal drugs available in India

Background: Most fungal infections require long-term therapy significantly increasing cost of therapy. High medical care cost should be of concern for policy makers and service providers. Hence, a study was planned to analyze cost ratio and percentage (%) cost variations of antifungal drugs available in India. Aim and Objectives: The aim of the study was to evaluate cost of different brands of antifungal drugs available in India and to analyze cost ratio and cost variations of different brands of antifungal drugs. Materials and Methods: Maximum and minimum price of each drug was noted in Indian Rupee, using “CIMS” April to July 2021; “Drug Today” April to July 2021 Vol - 1 and 2; and “Indian Drug Review” 2021. Percentage cost variation and cost ratio for individual drugs were compared. Results: Among oral antifungal drugs, Terbinafine 250 mg has highest cost ratio 89.071 and 8807.1% price variation. Griseofulvin 250 mg has lowest cost ratio 1.169 and 16.98% price variation. Among parenteral antifungal drugs, Amphotericin B 50 mg has highest cost ratio 17.088 and 1608.83% price variation. Caspofungin (50 and 70 mg) has least cost ratio and % price variation. Among single drug topical preparations, Clotrimazole 1% powder formulation has highest cost ratio and % price variation 22.48 and 2144.89%, respectively. Ketoconazole 2% solution formulation has least cost ratio and % price variation 1.233 and 23.33%, respectively. Conclusions: Long-term antifungal therapy requires patient compliance and thereby increased adherence to treatment which is achieved by switching to cost-effective regimen and by making Pharmacoeconomics an integral part of Undergraduate and Postgraduate Curriculum.

Prevalence and antimycotic susceptibility profile of Candida species in the oral cavities of HIV/AIDS patients and pregnant women in Nsukka, Nigeria

Aims@#The present study determined Candida species occurrence in the mouth of HIV/AIDS, pregnant women and healthy individuals, and Candida susceptibility to antimycotics.@*Methodology and results@#A cross-sectional study of the Candida species occurrence and their in vitro sensitivity to nystatin, clotrimazole, ketoconazole and fluconazole was studied. Oral swabs were taken from the dorsum of the tongue of 63 HIV/AIDS patients, 38 pregnant women and 53 apparently healthy humans served as control. All participants gave their consent. The samples were cultured for isolation of Candida species. The susceptibility of commonly used antimycotics against Candida species was determined using agar-well and disc-diffusion methods. The broth dilution method was adopted in the determination of the minimum inhibitory concentration of the drugs. The rate of Candida species colonization in HIV/AIDS patients was higher than that among pregnant women and apparently healthy humans. Candida albicans had the highest frequency. Candida species displayed higher sensitivity to nystatin and clotrimazole than ketoconazole and fluconazole. Candida albicans exhibiting low sensitivity to fluconazole were found in the mouth of AIDS patients, pregnant women and apparently healthy humans.@*Conclusion, significance and impact of study@#Candida species prevalence was highest among HIV patients. Candida albicans had the highest frequency among the study groups and had reduced susceptibility to fluconazole. The findings of the study underscore the need for regular surveillance and susceptibility testing of Candida isolates before prescription of antimycotics, especially in cases of chronic infection, as well as the development of safe and efficacious treatment alternatives since Candida isolates are becoming less susceptible to fluconazole.

Research progress of new antimicrobial agents for drug-resistant pathogenic bacteria / 中华临床感染病杂志

This article reviews the status quo of new antimicrobial agents that have been approved or undergoing phase Ⅱ/Ⅲ clinical trials in last five years at home and abroad, including new β-lactamase inhibitors and their compound preparations, oxazolidinones, tetracyclines, aminoglycosides, glycopeptides, quinolones, new antifungal agents, cyclic lipopeptides and new anti-mycobacterial agents. The antibacterial activities, main mechanisms of drug resistance, and progress of clinical studies of 27 new drugs were introduced to provide a reference for their clinical application.

Study of pathogen of oral candidias / Шинэ санаа Шинэ нээлт

Background@#Oral candidiasis, which is one of the most common diseases of the mucous membrane, is carried in the mouth of about 17-75% of healthy population. And 51-74% of this healthy population is asymptomatic. However, oral candidiasis is found in 50-65% of the individuals with dentures, is found in 67% of elders over 75 years old and is found in 85% of the patients with oral cancer. The most common causative organism is C.albicans with 43.7%, less commonly C.glabrata and C.tropicalis. According to some researches, the occurrence of the oral candidiasis has been increasing continuously for last 20-30 years, and has strong tendency to consistently increase for the 21st century. @*Methods@#Total 50 patients were participated in this study, including; the patients with full denture from Department of Prosthodontics of The Dental Center of Ulaanbaatar, and patients with evident symptoms of candidiasis from Department of Neck and Head Surgery and Department of Radiation Therapy of National Cancer Center of Mongolia. The study was carried out by descriptive study type, based on the patients’ questionnaire survey, physical examination and laboratory tests.@*Results@#The oral candidiasis causing pathogen Candida was found in 100% of following patients including; the patients with full denture and the patients having head and neck radiation therapy. For the patients with full denture, Candida albicans was the most commonly implicated organism with 53%, Candida tropicalis 21% and Candida krusei 11%. For the patients with radiation therapy for head and neck cancer, most common pathogen was Candida albicans with 64% and Candida tropicalis with 7%.@*Conclusions@#Main causative pathogens for the patients with full denture are C.albicans (53%), С.tropicalis (21%), and for the patients with radiotherapy for head and neck cancer is C. albicans (64%). 95% of the participants who were diagnosed with oral candidiasis were resistant to Colistin and 100% sensitive to Nystatin and Miconazole.

Effect of Yinlian gargle combined with sodium bicarbonate for the adults with oral fungal infections of acute myeloid leukemia chemotherapy induced myelosuppression / 国际中医中药杂志

Objective@#To evaluate the efficacy of Yinlian gargle combined with Sodium bicarbonate on treatment of adult with oral fungal infections of acute myeloid leukemia chemotherapy Induced myelosuppression.@*Methods@#Totally 120 patients with acute myeloid leukemia for chemotherapy Induced myelosuppression complicated with oral fungal infections were randomly divided into the western medicine group, the traditional Chinese medicine (TCM) group, the integrated TCM and western medicine group and the control group, with 30 patients in each group. The integrated TCM and western medicine group was treated by Yinlian gargle and sodium bicarbonate solution alternately, the TCM group was treated by Yinlian gargle, the western medicine group was treated by Yinlian gargle and sodium bicarbonate solution, and the control group was treated by basic treatment and normal saline 4 times a day for 5 days. Before and after treatment, the Oral pH, white spot area, the safety were observed. And to calculate the total efficiency of each group.@*Results@#The oral pH (6.98 ± 0.13 vs. 6.57 ± 0.14, 6.61 ± 0.11, 6.23 ± 0.09, F=273.930 )in the integrated TCM and western medicine group were significantly higher than those among other groups (P<0.05). The white spot area (2.21 ± 1.93 mm2 vs. 6.32 ± 2.35 mm2, 5.99 ± 2.64 mm2, 7.83 ± 2.56 mm2, F=29.842) in the integrated TCM and western medicine group were significantly lower than those among other groups (P<0.05). The effective rate in TCM and western medicine group was 96.7% (29/30), TCM group 60.0% (18/30), western medicine group 63.3% (19/30), and the control group 31.0% (9/29), which showed significantly difference among four groups (χ2=27.425, P<0.01).@*Conclusions@#The Yinlian gargle combined with sodium bicarbonate on treatment of adult acute myeloid leukemia chemotherapy induced myelosuppression with oral fungal infections was effective.

Evaluación de la indicación, consumo y costos de antifúngicos en un hospital pediátrico de Chile / Evaluation of the prescription, consumption and costs of antifungal drugs in a pediatric hospital in Chile

Resumen Introducción: El incremento de la enfermedad fúngica invasora (EFI) en pacientes inmunocomprometidos ha conducido a la frecuente prescripción de fármacos altamente activos pero de elevado costo económico. Objetivo: Caracterizar el uso de antifúngicos, evaluar su indicación y determinar consumo y costos asociados. Métodos: Estudio descriptivo, retrospectivo, desde enero de 2015 a abril de 2016. Auditoría de prescripciones y revisión de fichas clínicas; cada prescripción se clasificó de acuerdo a si correspondía a una EFI posible, probable o probada. Se calcularon consumos y costos de tratamientos. Resultados: Se auditaron 152 prescripciones de antifúngicos en 79 pacientes. El costo total de los medicamentos antifúngicos fue de US$ 714.413. El 52,1% del gasto (US $ 372.319) correspondió a indicaciones en EFI probada, 10,7% (US $ 76.377) EFI probable, 0.8% (US $ 5.638) no-EFI, 12,2% (US $ 87.459) EFI posibles y 1,5% (US $ 10.896) EFI descartada y 22,6% (US$ 161.723) fue profilaxis. El mayor consumo fue en indicaciones relacionadas a EFI probada con un DOT probada de 10,54 días, siendo anfotericina B liposomal y voriconazol iv los fármacos con mayor consumo con un DOTprobada AnBL de 3,15 y DOT probada voriconazol iv de 3,01. Conclusiones: El consumo de medicamentos antifúngicos genera altos costos correspondiente al 12% del presupuesto total de farmacia de nuestra institución. El gasto se asoció principalmente a indicaciones en EFI probadas, voriconazol y anfotericina B liposomal los con mayor consumo, lo que sumado a su alto costo y días prolongados de terapia generan un gran impacto en el presupuesto.

Background: The increase of invasive fungal disease (IFD) in immunocompromised patients has led to the frequent prescription of highly active antifungal drugs but with a high economic cost. Aim: To characterize the use of antifungals drugs, evaluate its prescription and determine consumption and associated costs. Methods: Retrospective descriptive study from January 2015 to April 2016. Audit of prescriptions and review of clinical files. Each prescription was classified according to whether it corresponded to a possible, probable or proven invasive fungal disease (IFD). Consumptions and treatment costs were calculated. Results: 152 antifungal prescriptions were audited in 79 patients. The total cost of antifungal medications was US $ 714,413. 52.1% of the expenditure (US $ 372,319) corresponded to indications in proven IFD, 10.7% (US $ 76,377) probable IFD, 0.8% (US $ 5,638) non-IFI, 12.2% (US $ 87,459) IFD possible and 1.5% (US $ 10,896) non-IFD and 22.6% (US $ 161,723) was prophylaxis. The highest consumption was in indications related to IFD tested with a proven DOT of 10.54 days, with liposomal amphotericin B and iv voriconazole the drugs with the highest consumption with a DOT probable_AnBL of 3.15 and DOT proven voriconazole iv of 3.01. Conclusions: The consumption of antifungal drug medications generates high costs at 12% of the total pharmacy budget of our institution. The expense was associated mainly with the indications in IFI tested the voriconazole and amphotericin B liposomal with the highest consumption which added to its high cost and prolonged days of general therapy a big impact in the budget.

The war on cryptococcosis: A Review of the antifungal arsenal

Cryptococcal meningitis is the most common central nervous system infection in the world today. It occurs primarily, but not exclusively, in immunocompromised individuals and despite substantial improvement in management of clinical events like AIDS, the numbers of cases of cryptococcosis remain very high. Unfortunately, despite several antifungal agents available for treatment, morbidity and mortality rates remain high with this fungal infection. In this Review, we will describe the treatments and strategies for success, identify the failures, and provide insights into the future developments / improvements for management. This sugar-coated yeast can play havoc within the human brain. Our goals must be to either prevent or diagnose disease early and treat aggressively with all our clinical tools when disease is detected.

Effect of povidone iodine combined with antifungal drugs in the treatment of fungal keratitis / 中国生化药物杂志

Objective To analyze the effect of combined use of povidone iodine and antifungal drugs in the treatment of fungal keratitis.Methods 96 cases of fungal keratitis patients suffering from the disease as the research object from March 2014 to March 2016 in our hospital,according to different treatment methods,they were divided into observation group and control group,48 cases in each group,control group received povidone iodine topical treatment,the observation group used povidone iodine and topical antifungal agents the treatment,the clinical efficacy of the two groups received.Results The total efficiency of the observation group was 97.9％higher than that of the control group 85.4％,the difference was statistically significant(χ2=4.909,P0.05 share of the observation group was significantly higher than the control group,the difference was statistically significant(χ2=6.042,P< 0.05); There was no significant difference in the incidence of adverse reactions between the two groups.Conclusion The combined use of povidone iodine and antifungal drugs in the treatment of fungal keratitis can produce a very significant therapeutic effect,effectively improve the visual acuity of patients,and has high application value.

Utilization Analysis of Antifungal Drugs in Nanjing Area during 2013 and 2015 / 中国药师

Objective:To evaluate the utilization of antifungal drugs in Nanjing area, and provide clinical reference for the rational use of antifungal drugs. Methods:According to the sales data of antifungal drugs in 34 hospitals in Nanjing area from 2013 to 2015, the utilization of antifungal drugs was analyzed in respects of consumption sum, DDDs and DDC. Results:The consumption sum and use of antifungal drugs increased year by year. The maximum amount of consumption sum growth rate was 41. 13%. Triazole drugs oc-cupied the top of consumption sum during the past three years, and the sales amount accounted for more than 60% of all. In term of consumption sum, voriconazole, fluconazole, itraconazole and caspofungin ranked top 4 of antifungal drugs. Clotrimazole topical prepa-rations and oral itraconazole ranked top 2 of DDDs, and caspofungin, micafungin and voriconazole ranked top 3 of DDC. Conclusion:The clinical application of antifungal drugs continues to increase during 2013 and 2015. Invasive fungal infection is a lethal factor at high risk. Choosing reasonable, effective, safe and economic of antifungal drugs is the first principle in clinical treatment.

Candida glabrata among Candida spp. from environmental health practitioners of a Brazilian Hospital

Abstract The incidence of the species Candida albicans and non-albicans Candida was evaluated in a Brazilian Tertiary Hospital from the environment and health practitioners. In a 12-month period we had a total positivity of 19.65% of Candida spp. The most recurring non-albicans Candida species was C. glabrata (37.62%), generally considered a species of low virulence, but with a higher mortality rate than C. albicans. Subsequently, C. parapsilosis (25.74%) and C. tropicalis (16.86%) were the second and third most commonly isolated species. Considering the total samples collected from the emergency room and from the inpatient and the pediatric sector, 19.10% were positive for Candida spp., with the predominance of non-albicans Candida species (89.42%). The high percentage of positivity occurred in the hands (24.32%) and the lab coats (21.88%) of the health care assistants. No sample of C. albicans presented a profile of resistance to the drugs. All the non-albicans Candida species presented a decreased susceptibility to miconazole and itraconazole, but they were susceptible to nystatin. Most of the isolates were susceptible to fluconazole and amphotericin B. As expected, a high resistance rate was observed in C. glabrata and C. krusei, which are intrinsically less susceptible to this antifungal agent. The contamination of environmental surfaces by Candida spp. through hand touching may facilitate the occurrence of Candida infections predominantly in immunocompromised patients. In addition to that, the antifungal agents used should be carefully evaluated considering local epidemiologic trends in Candida spp. infections, so that therapeutic choices may be better guided.

Analysis of the Correlation between the Use Density of Antibiotic and Antifungal Drugs and the Positive Rate of Aspergillus / 医药导报

Objective To investigate the correlation between the use density of antibiotic and antifungal drugs and the positive rate of aspergillus in our hospital from 2009 to 2013,in order to provide a scientific basis for rational use of antibiotic and antifungal drugs. Methods The use density of carbapenems,two third-generation cephalosporins,and antifungal drugs,and the positive rate of aspergillus in our hospital from 2009 to 2013 were studied retrospectively. Their correlation was analyzed using SPSS software. Results There was significantly positive correlation between the use density of imipenem and that of fluconazole (r=0.913,P<0.05).The use density of biapenem was positively correlated with that of voriconazole (r=0.915,P<0.05).The use density of biapenem and that of voriconazole was positively correlated with positive rate of aspergillus,respectively ( r=0.918,r=0.955,both P<0.05).The other antibiotic and antifungal drugs were not significantly correlated to the positive rate of aspergillus.

Analysis of the Application of Antifungal Drugs in Haematologic Patients from a Third Grade Class A Hos-pital during 2013-2014 / 中国药房

OBJECTIVE:To provide reference for the formulation of correct antifungal treatment strategy,and to promote stan-dard use of antifungal agent. METHODS:A retrospective survey was conducted for 138 haematologic patients from May 2013 to May 2014 in a third grade class A hospital,of whom all had used antifungal drugs during hospitalization. We collected all patients' information and analyzed it statistically. RESULTS:Of 138 haematologic patients,3 were proven IFD (all were Candida infec-tion),6 were probable IFD,12 were possible IFD,and 117 were undefined IFD. The positive rates of fungi pathogenic detection, fungal smear,G-test,and GM-test were 15.3%,9.4%,6.4% and 23.4% respectively. 6 kinds of antifungal were used,and vori-conazole had the highest frequency,followed by fluconazole,itraconazole,amphotericin B,caspofungin and micafungin. 62.3%patients used only one kind of antifungal,but 15.9% patients used 2 or more kinds of antifungal. The average medication course was 20.5 days(1 day to 125 days). Irrational drug use showed improper drug selection,unreasonable dose,and replacing antifun-gal with insufficient basis. CONCLUSIONS:The antifungal use in haematologic patients in the hospital is consistent with the re-quirements of guidelines,but there are still some issues as insufficient antifurgal drug treatment course to be further standardized.

Formulation and Evaluation of Ketoconazole Polymeric Films for Topical Application.

The objective of the current paper was to prepare and evaluate various polymeric films for fungal infection treatment and its impact on volunteer patients. Different Eudragit polymeric films containing Ketoconazole as antifungal drug were prepared by solvent casting technique. The prepared films were tested for their physicomechanical properties as tensile strength, physical endurance, elasticity, water vapor permeation and water loss. The release of ketoconazole from the prepared medicated films was examined. It is involved 20 volunteers suffering from legs fungal infection. Ten of the patients used the films and a follow up study was carried out for 14 days, in comparison with other patients who applied ketoconazole medicated ointment, cream gel and Emulgel. The results revealed that films prepared with Eudragit RL 100 containing glyceryl triacetate produced maximum release of ketoconazole both In vitro and In vivo as compared with other topical dosage forms as ointment, cream, gel and Emulgel. Moreover, the films constitute a simple and convenient method for treatment of various fungal infections. As conclusion, the use of antifungal drugs such as Ketoconazole incorporated in polymeric films, the output results provided promised evidence in the treatment of dermatophytosis.

Una nueva generación de antifúngicos para el tratamiento de las micosis superficiales / A new generation of antifungals for the treatment of dermatomycosis

Las infecciones fúngicas superficiales responden bien a los tratamientos habituales en la mayoría de los casos pero, en determinadas situaciones, constituyen un problema. En su mayoría se trata de infecciones producidas por levaduras del género Candida y Malassezia y por hongos dermatofitos. Estas infecciones han visto incrementada su prevalencia junto con la selección de determinadas especies, la reducción de la sensibilidad a los antifúngicos y la aparición de fenómenos de resistencia in vitro e in vivo. La investigación para encontrar el antifúngico ideal aún continúa y en este sentido actualmente se están ensayando distintas estrategias de investigación sobre drogas para el tratamiento sistémico y tópico de las dermatomicosis.

Superficial fungal infections frequently caused by Candida spp. and Malassezia spp yeasts and dermatophytes fungi, have good response to common treatments in the majority of cases, but in some cases failure are described. Prevalence of these infections has been increased with the selection of certain species, reduced sensitivity to antifungal agents and the emergence of in vitro and in vivo resistance phenomena. The research to find the ideal antifungal still continues and in this sense are being currently tested different strategies for research on systemic and topical drugs for dermatomycosis treatment.

Case Analysis of the Participation of Clinical Pharmacist in Antifungal Drug Treatment of New Type Crypto-coccal Meningitis / 中国药房

OBJECTIVE:To explore the method of pharmaceutical care for antifungal drug treatment of new type crypto-coccal meningitis by clinical pharmacist. METHODS:Clinical pharmacist participated in the drug treatment process for a pa-tient with new type cryptococcal meningitis. Clinical pharmacist provided pharmaceutical care in following aspects:assisting doctor to optimize antifungal drugs treatment plan,providing patients pharmaceutical monitoring and medication education, etc. During amphotericin B treatment,the patient developed refractory hypokalemia. Clinical pharmacists suggested doctors to reduce the dose of amphotericin B and additionally use voriconazole for antifungal treatment. RESULTS:The patient devel-oped refractory hypokalemia no more after the plan was adjusted. After 11 weeks of systematic antifungal treatment,the pa-tient was on the mend. CONCLUSIONS:The participation of clinical pharmacist in antifungal treatment of new type cryptococ-cal meningitis indicates that following the instructions,but not lost flexible disposal;providing service actively,and details is guarantee of safety.

Environmental isolation, biochemical identification, and antifungal drug susceptibility of Cryptococcus species

Introduction The incidence of opportunistic fungal infections has increased in recent years and is considered an important public health problem. Among systemic and opportunistic mycoses, cryptococcosis is distinguished by its clinical importance due to the increased risk of infection in individuals infected by human immunodeficiency virus. Methods To determine the occurrence of pathogenic Cryptococcus in pigeon excrement in the City of Araraquara, samples were collected from nine environments, including state and municipal schools, abandoned buildings, parks, and a hospital. The isolates were identified using classical tests, and susceptibility testing for the antifungal drugs (fluconazole, itraconazole, voriconazole, and amphotericin B) independently was also performed. After collection, the excrement samples were plated on Niger agar and incubated at room temperature. Results A total of 87 bird dropping samples were collected, and 66.6% were positive for the genus Cryptococcus. The following species were identified: Cryptococcus neoformans (17.2%), Cryptococcus gattii (5.2%), Cryptococcus ater (3.5%), Cryptococcus laurentti (1.7%), and Cryptococcus luteolus (1.7%). A total of 70.7% of the isolates were not identified to the species level and are referred to as Cryptococcus spp. throughout the manuscript. Conclusions Although none of the isolates demonstrated resistance to antifungal drugs, the identification of infested areas, the proper control of birds, and the disinfection of these environments are essential for the epidemiological control of cryptococcosis. .

Avaliação clínica e laboratorial do tratamento da estomatite protética através de produtos naturais / Clinical and laboratory evaluation of denture stomatitis treatment using natural products

O aumento da resistência aos antifúngicos convencionais e os possíveis efeitos colaterais destes fármacos têm estimulado pesquisas sobre produtos naturais com potencial antimicrobiano e baixa toxicidade. Assim, o objetivo desta pesquisa foi realizar uma avaliação clínica e laboratorial do tratamento da estomatite protética (EP) através de produtos naturais, por meio de cultura micológica quantitativa, de microscopia confocal e de análise das propriedades superficiais de uma resina acrílica. Em todas as avaliações, os grupos experimentais foram divididos de acordo com as seguintes substâncias: G1 - água destilada estéril; G2 - nistatina; G3 - extrato alcoólico de própolis a 20%; G4 - gel de Punica granatum Linné; G5 - gel de Uncaria tomentosa (Imuno-Max Gel). Para a cultura micológica quantitativa, 30 pacientes diagnosticados com EP utilizaram os seus respectivos medicamentos três vezes por dia, durante 14 dias, associados à escovação das próteses com dentifrício. Nas avaliações, foram coletados materiais das áreas eritematosas da mucosa palatina e das áreas correspondentes na prótese total superior. Este procedimento foi realizado antes do tratamento (T0), após 14 dias do início do tratamento (T1) e 30 dias após a suspensão do uso dos medicamentos (T2). Os dados obtidos foram submetidos ao teste não-paramétrico de Friedman para comparações intragrupos e ao teste de Kruskal-Wallis para comparações intergrupos. Para análise através de microscopia confocal, 30 espécimes de uma resina acrílica termopolimerizável foram inoculados com C. albicans para a formação do biofilme e, em seguida, imersos em sua respectiva droga. Os biofilmes remanescentes sobre os espécimes foram corados através de fluorocromos indicadores de viabilidade celular. Os dados obtidos foram analisados através do teste não paramétrico de Kruskal-Wallis e do pós-teste de comparação múltipla de Dunn. Para análise das propriedades superficiais, 50 espécimes de uma resina acrílica termopolimerizável...

The increased resistance to conventional antifungal drugs and their possible side effects have stimulated research on natural products with antimicrobial activity and low toxicity. This study comprised a clinical and laboratory evaluation of the treatment of denture stomatitis (DS) using natural products by quantitative mycological culture, confocal microscopy and analysis of surface properties of an acrylic resin. In all evaluations, the experimental groups were divided according to the following substances: G1 - sterile distilled water; G2 - nystatin (Micostatin); G3 - 20% propolis alcoholic extract; G4 - P. granatum Linné gel; G5 - Uncaria tomentosa gel (Imuno-Max Gel). For quantitative mycological culture, 30 patients diagnosed with DS used their respective medicines three times a day for 14 days, associated with denture brushing with dentifrice. For the analysis, material was collected from erythematous areas of the palatal mucosa and from corresponding areas on the maxillary denture. This procedure was performed before treatment (T0), at 14 days after treatment onset (T1) and 30 days after interrupting the use of drugs (T2). Data were analyzed by the non-parametric Friedman test for intragroup comparisons and Kruskal-Wallis test for intergroup comparisons. For analysis by confocal microscopy, 30 specimens of a polymerized acrylic resin were inoculated with C. albicans for biofilm development and then immersed in the respective drugs. The remaining biofilms on the specimens were stained using fluorochrome indicators of cell viability. Data were analyzed by non-parametric Kruskal-Wallis test and Dunn's multiple comparison post-hoc test. For the analysis of surface properties, 50 specimens of polymerized acrylic resin were fabricated, polished and tested for initial verification of roughness and microhardness (T0). Then, the specimens were individually immersed in the respective drugs for 24 hours. After 14 days of immersion (T1), the surfasse...

Avaliação clínica e laboratorial do tratamento da estomatite protética através de produtos naturais / Clinical and laboratory evaluation of denture stomatitis treatment using natural products

O aumento da resistência aos antifúngicos convencionais e os possíveis efeitos colaterais destes fármacos têm estimulado pesquisas sobre produtos naturais com potencial antimicrobiano e baixa toxicidade. Assim, o objetivo desta pesquisa foi realizar uma avaliação clínica e laboratorial do tratamento da estomatite protética (EP) através de produtos naturais, por meio de cultura micológica quantitativa, de microscopia confocal e de análise das propriedades superficiais de uma resina acrílica. Em todas as avaliações, os grupos experimentais foram divididos de acordo com as seguintes substâncias: G1 - água destilada estéril; G2 - nistatina; G3 - extrato alcoólico de própolis a 20%; G4 - gel de Punica granatum Linné; G5 - gel de Uncaria tomentosa (Imuno-Max Gel). Para a cultura micológica quantitativa, 30 pacientes diagnosticados com EP utilizaram os seus respectivos medicamentos três vezes por dia, durante 14 dias, associados à escovação das próteses com dentifrício. Nas avaliações, foram coletados materiais das áreas eritematosas da mucosa palatina e das áreas correspondentes na prótese total superior. Este procedimento foi realizado antes do tratamento (T0), após 14 dias do início do tratamento (T1) e 30 dias após a suspensão do uso dos medicamentos (T2). Os dados obtidos foram submetidos ao teste não-paramétrico de Friedman para comparações intragrupos e ao teste de Kruskal-Wallis para comparações intergrupos. Para análise através de microscopia confocal, 30 espécimes de uma resina acrílica termopolimerizável foram inoculados com C. albicans para a formação do biofilme e, em seguida, imersos em sua respectiva droga. Os biofilmes remanescentes sobre os espécimes foram corados através de fluorocromos indicadores de viabilidade celular. Os dados obtidos foram analisados através do teste não paramétrico de Kruskal-Wallis e do pós-teste de comparação múltipla de Dunn. Para análise das propriedades superficiais, 50 espécimes de uma resina acrílica termopolimerizável...

The increased resistance to conventional antifungal drugs and their possible side effects have stimulated research on natural products with antimicrobial activity and low toxicity. This study comprised a clinical and laboratory evaluation of the treatment of denture stomatitis (DS) using natural products by quantitative mycological culture, confocal microscopy and analysis of surface properties of an acrylic resin. In all evaluations, the experimental groups were divided according to the following substances: G1 - sterile distilled water; G2 - nystatin (Micostatin); G3 - 20% propolis alcoholic extract; G4 - P. granatum Linné gel; G5 - Uncaria tomentosa gel (Imuno-Max Gel). For quantitative mycological culture, 30 patients diagnosed with DS used their respective medicines three times a day for 14 days, associated with denture brushing with dentifrice. For the analysis, material was collected from erythematous areas of the palatal mucosa and from corresponding areas on the maxillary denture. This procedure was performed before treatment (T0), at 14 days after treatment onset (T1) and 30 days after interrupting the use of drugs (T2). Data were analyzed by the non-parametric Friedman test for intragroup comparisons and Kruskal-Wallis test for intergroup comparisons. For analysis by confocal microscopy, 30 specimens of a polymerized acrylic resin were inoculated with C. albicans for biofilm development and then immersed in the respective drugs. The remaining biofilms on the specimens were stained using fluorochrome indicators of cell viability. Data were analyzed by non-parametric Kruskal-Wallis test and Dunn's multiple comparison post-hoc test. For the analysis of surface properties, 50 specimens of polymerized acrylic resin were fabricated, polished and tested for initial verification of roughness and microhardness (T0). Then, the specimens were individually immersed in the respective drugs for 24 hours. After 14 days of immersion (T1), the surfasse...

Antimicrobial effects of allicin and ketoconazole on trichophyton rubrum under in vitro condition

Dermatophytosis is caused by a group of pathogenic fungi namely, dermatophytes, is among the most prevalent infectious diseases worldwide. Azole drugs are widely used in the treatment of dermatomycosis, but can cause various side effects and drug resistance to the patients. Hence, for solving this problem can be used from the plant extract as alternative for chemical drugs. Allicin is a pure bioactive compound isolated from garlic was tested for its potential as a treatment of dermatomycosis in this study. This study evaluated the in vitro efficacy of pure allicin against ten isolates of Trichophyton rubrum and the MIC50 and MIC90 ranged from 0.78-12.5 µg/ml for allicin. The results revealed that the order of efficacy based on the MICs values, all isolates showed almost comparable response to allicin and ketoconazole except for some isolates, at 28 ºC for both 7 and 10 days incubation. Mann-Whitney test indicate that MICs at 7 days incubation was not observed a significant difference between the effects of allicin and ketoconazole (p > 0.05), but MICs at 10 days incubation, a significant difference was observed (p < 0.05). On the other side, time kill studies revealed that allicin used its fungicidal activity within 12-24 h of management in vitro as well as ketoconazole. In conclusion, allicin showed very good potential as an antifungal compound against mycoses-causing dermatophytes, almost the same as the synthetic drug ketoconazole. Therefore, this antifungal agent appears to be effective, safe and suitable alternative for the treatment of dermatomycosis.